Chinese english Germany Japanese Korea

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo-

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo- Struktur
1054130-93-6
CAS-Nr.
1054130-93-6
Englisch Name:
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo-
Synonyma:
1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-methylpropyl)benzoyl]-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acid;3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo-
CBNumber:
CB72605679
Summenformel:
C28H30FN3O4
Molgewicht:
491.55
MOL-Datei:
1054130-93-6.mol
Request For Quotation

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo- Eigenschaften

Sicherheit

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Ipure Biology Co., Ltd 		+8613367258412
 ada@ipurechemical.com China 10326 58
Nanjing Chemlin Chemical Co., Ltd 025-83697070
info@chemlin.com.cn China 18071 64
  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-Methylpropyl)benzoyl]-1-piperazinyl]-4-oxo-
  • 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-[4-(2-methylpropyl)benzoyl]-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acid
  • 1054130-93-6
Copyright 2019 © ChemicalBook. All rights reserved